levofloxacin has been researched along with tetraphenylphosphonium chloride in 2 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (tetraphenylphosphonium chloride) | Trials (tetraphenylphosphonium chloride) | Recent Studies (post-2010) (tetraphenylphosphonium chloride) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 7 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakaminami, H; Noguchi, N; Sasatsu, M | 1 |
| Alenazy, R; Gu, X; Jin, C; Ma, S; Modi, ND; Mowla, R; Polyak, SW; Qin, Y; Tan, JQE; Venter, H; Wang, Y | 1 |
2 other study(ies) available for levofloxacin and tetraphenylphosphonium chloride
| Article | Year |
|---|---|
Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Fluoroquinolones; Membrane Transport Proteins; Plasmids; Staphylococcus aureus | 2010 |
Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Molecular Structure; Multidrug Resistance-Associated Proteins; Naphthalimides; Structure-Activity Relationship | 2019 |